The timing and probability of treatment switch under cost uncertainty: an application to patients with gastrointestinal stromal tumor.
Explore this paper's citation graph
Summary
The results of the empirical application suggest that the first-line treatment may be the better choice when considering lifetime welfare, and under uncertainty and irreversibility, low-risk patients must begin the second- line treatment as soon as possible, which is precisely when the second -line treatment is least valuable.
- Type
- article
- Published
- 2014-03-01
- Cited by
- 7
- References
- 32
- Access
- Open access
- OpenAlex
- https://openalex.org/W2097292308
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:29331315
Keywords
Stromal tumor, Stromal cell, Computer science, Medicine, Internal medicine
References
- 対数正規分布(Lognormal Distribution)のあてはめについて
- A Pilot Study of Value of Information Analysis to Support Research Recommendations for NICE
- The art of smooth pasting
- PCN18 ECONOMIC EVALUATION OF SUNITINIB VS. IMATINIB IN SECOND LINE FOR GASTROINTESTINAL TUMOR (GIST) IN BRAZIL
- Implications of the Interaction Between Insurance Choice and Medical Care Demand
- Establishing the cost-effectiveness of new pharmaceuticals under conditions of uncertainty--when is there sufficient evidence?
- Use, option and externality values: are contingent valuation studies in health care mis-specified?
- The capital gains effect in the demand for housing
- When Is a Coinsurance-Type Insurance Policy Inferior or Even Giffen?
- Investment Under Uncertainty
- Cost Effectiveness of Imatinib Mesylate in the Treatment of Advanced Gastrointestinal Stromal Tumours
- Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day: a systematic review and economic evaluation.
- Medical technology adoption, uncertainty, and irreversibilities: is a bird in the hand really worth more than in the bush?
- Hysteresis, Import Penetration, and Exchange Rate Pass-Through
- Insurance as a Giffen good
- Antiretroviral Therapy: Time To Think Strategically
- A pharmaco-economic analysis of second-line treatment with imatinib or sunitinib in patients with advanced gastrointestinal stromal tumours
- The economic impact of cytoreductive surgery and tyrosine kinase inhibitor therapy in the treatment of advanced gastrointestinal stromal tumours: a Markov chain decision analysis.
- Entry and Exit Decisions under Uncertainty
- The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies.
Cited by
- HIV patients' decision of switching to second-line antiretroviral therapy in India
- Financial Estimation of the Uncertainty in Medicine Using Present Value of Medical Fees and a Mortality Risk Prediction Model: a Retrospective Cohort Study
- On the timing and probability of Presurgical Teledermatology: how it becomes the dominant strategy
- Strategic flexibility in healthcare: an exploration of real options
- Challenges and Opportunities in Interdisciplinary Research and Real-World Data for Treatment Sequences in Health Technology Assessments
- Uncertainty Significantly Influences Healthcare Policy Decisions
- Insights from Financial Economics to Value Healthcare Investments that Reduce System-Level Risks: Example of Disease Elimination and Eradication
Related papers
- Genentech taps Affimed’s antibodies
- KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria
- Cardiac retransplantation in children.
- PD-09.06: Third kidney transplants: surgical aspects
- Avaliacao hemodinamica sequencial em transplante de coracao
- Thoracoscopic discectomy and fusion in the treatment of spinal deformities
- [Hepatic retransplant and acute Budd Chiari syndrome. Case report].